Ramelteon: A melatonin receptor agonist for the treatment of insomnia

V. Devi, P. Shankar

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalJournal of Postgraduate Medicine
Volume54
Issue number1
Publication statusPublished - 01-01-2008

Fingerprint

Melatonin Receptors
Sleep Initiation and Maintenance Disorders
Melatonin MT1 Receptor
Melatonin MT2 Receptor
Neurotransmitter Receptor
Sleep
Therapeutics
Safety
Pharmaceutical Preparations
ramelteon

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{c01b953c476049058e70d8dde58d9e72,
title = "Ramelteon: A melatonin receptor agonist for the treatment of insomnia",
abstract = "Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.",
author = "V. Devi and P. Shankar",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "54",
pages = "45--48",
journal = "Journal of Postgraduate Medicine",
issn = "0022-3859",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

Ramelteon : A melatonin receptor agonist for the treatment of insomnia. / Devi, V.; Shankar, P.

In: Journal of Postgraduate Medicine, Vol. 54, No. 1, 01.01.2008, p. 45-48.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Ramelteon

T2 - A melatonin receptor agonist for the treatment of insomnia

AU - Devi, V.

AU - Shankar, P.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.

AB - Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.

UR - http://www.scopus.com/inward/record.url?scp=39749172379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749172379&partnerID=8YFLogxK

M3 - Review article

C2 - 18296808

AN - SCOPUS:39749172379

VL - 54

SP - 45

EP - 48

JO - Journal of Postgraduate Medicine

JF - Journal of Postgraduate Medicine

SN - 0022-3859

IS - 1

ER -